RxSight, Inc.: net_income
| Value | {"amount": -48.6, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | RxSight, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8d01b49c-f0cd-4e3e-b1fe-708177ff0477
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-26-187240Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001111485/net-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8d01b49c-f0cd-4e3e-b1fe-708177ff0477
History
- supersedes {"amount": -48608000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0000950170-24-022073)